Anna Hamill
Director of Finance/CFO chez LAIRD SUPERFOOD, INC.
Fortune : 260 482 $ au 31/03/2024
Profil
Anna Kochetova Hamill is currently the Chief Financial Officer at Laird Superfood, Inc. She previously worked as the Senior Finance Director at Danone US, Inc. from 2003 to 2017 and as the Senior Finance Director-Premium Yogurt at Danone Medical Nutrition North America, Inc. from 2017 to 2018.
She also served as the Chief Financial Officer at Little Secrets Chocolate LLC.
Ms. Hamill holds an MBA from The Leeds School of Business and an undergraduate degree from Saint Petersburg State University of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LAIRD SUPERFOOD, INC.
1,15% | 15/03/2024 | 108 534 ( 1,15% ) | 260 482 $ | 31/03/2024 |
Postes actifs de Anna Hamill
| Sociétés | Poste | Début |
|---|---|---|
| LAIRD SUPERFOOD, INC. | Director of Finance/CFO | 01/07/2022 |
Anciens postes connus de Anna Hamill
| Sociétés | Poste | Fin |
|---|---|---|
Danone Medical Nutrition North America, Inc.
 Danone Medical Nutrition North America, Inc. Specialty StoresRetail Trade In 2008, Danone recorded an organic growth rate of 8.4% - practical proof that its business growth model truly works. With its operating margin increasing for the 14th year running, the group further strengthened its global standing: world no. 1 in fresh dairy products, world no. 2 in bottled waters, world no. 2 in baby nutrition and European no. 1 in medical nutrition. The group's performance is the result of a balanced strategy that builds on international expansion, a growing commitment to innovation, and strengthening health-oriented brands. In order to live up to its ambitions, Danone invests heavily in Research & Development - €208 million in 2008. One hundred percent of projects currently in the pipeline focus on health and nutrition. Three centuries after the benefits of Evian mineral water were discovered, over a century after Blédine was first marketed, and nearly a century after the first Danone yoghurt was retailed in a pharmacy, health innovation remains more than ever a driver of the group's business growth. 2008 confirmed that the previous year's acquisition of the Dutch group Numico was strategically sound. With this move, Danone incorporated into its strategy two profitable, fast-growing health-oriented business lines: medical nutrition and baby nutrition. They naturally round off the group's brand portfolio and are perfectly aligned with its mission to bring health through food to as many people as possible. Today Danone is the only food group to focus totally on health. | Corporate Officer/Principal | 01/03/2018 |
| WHITEWAVE FOODS CO | Director of Finance/CFO | 01/05/2017 |
Formation de Anna Hamill
| The Leeds School of Business | Masters Business Admin |
| Saint Petersburg State University of Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LAIRD SUPERFOOD, INC. | Consumer Non-Durables |
| Entreprise privées | 2 |
|---|---|
Danone US, Inc.
 Danone US, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Danone US, Inc. engages in the manufacture, marketing, distribution, and sale of branded plant-based foods and beverages, coffee creamers and beverages, premium dairy products, and organic produce. Its brands include Activia, Dan Active, Danimals, Danone, Danonino, Horizon, International Delight, Dannon Light + Fit, Oikos, Silk, So Delicious Dairy Free, SToK, Two Good, Wallaby Organic, YoCrunch, and Yocream. The company was founded in 1977 and is headquartered in Broomfield, CO. | Consumer Non-Durables |
Danone Medical Nutrition North America, Inc.
Danone Medical Nutrition North America, Inc. Specialty StoresRetail Trade In 2008, Danone recorded an organic growth rate of 8.4% - practical proof that its business growth model truly works. With its operating margin increasing for the 14th year running, the group further strengthened its global standing: world no. 1 in fresh dairy products, world no. 2 in bottled waters, world no. 2 in baby nutrition and European no. 1 in medical nutrition. The group's performance is the result of a balanced strategy that builds on international expansion, a growing commitment to innovation, and strengthening health-oriented brands. In order to live up to its ambitions, Danone invests heavily in Research & Development - €208 million in 2008. One hundred percent of projects currently in the pipeline focus on health and nutrition. Three centuries after the benefits of Evian mineral water were discovered, over a century after Blédine was first marketed, and nearly a century after the first Danone yoghurt was retailed in a pharmacy, health innovation remains more than ever a driver of the group's business growth. 2008 confirmed that the previous year's acquisition of the Dutch group Numico was strategically sound. With this move, Danone incorporated into its strategy two profitable, fast-growing health-oriented business lines: medical nutrition and baby nutrition. They naturally round off the group's brand portfolio and are perfectly aligned with its mission to bring health through food to as many people as possible. Today Danone is the only food group to focus totally on health. | Retail Trade |
